Previous Article | Next Article ![]()
Applied and Environmental Microbiology, August 2000, p. 3499-3505, Vol. 66, No. 8
Departments of Botany and Plant
Pathology1 and of Food Science and Human
Nutrition,3 National Center for Food
Safety and Toxicology,4 Department of
Energy Plant Research Laboratory,5 and
The Center for Integrated Plant
Systems,2 Michigan State University, East
Lansing, Michigan 48824
Received 25 October 1999/Accepted 15 May 2000
The efficacy of cloning a recombinant mycotoxin antibody in plants
was tested using Arabidopsis as a model. An antizearalenone single-chain Fv (scFv) DNA fragment was first cloned in the newly constructed phage display vector (pEY.5) and then recloned in the plant
transformation vector pKYLX71::35S2. After
transformation, constructs of antizearalenone scFv were introduced into
immature Arabidopsis seeds via Agrobacterium
tumefaciens mediation by vacuum infiltration. Only plants
transformed with the construct containing a PR-1b signal peptide
sequence produced transgenic offspring. The antizearalenone scFv
"plantibody" from these transgenic plants bound zearalenone with a
high affinity (50% inhibitory concentration, 11.2 ng/ml) that was
comparable to that of bacterially produced scFv antibody and the parent
monoclonal antibody (MAb). By electron microscopic immunogold labeling,
the presence of antizearalenone scFv was detected mainly in the
cytoplasm and only occasionally outside the cell. Like bacterially
produced scFv antibody, antizearalenone scFv plantibody exhibited
greater sensitivity to methanol destabilization than did the parent
MAb. The sensitivity of antizearalenone scFv plantibody to acidic
disassociation was similar to the sensitivities of bacterially produced
scFv antibody and MAb. Expression of specific plantibodies in crops might be useful for neutralizing mycotoxins in animal feeds and for
reducing mycotoxin-associated plant diseases.
Zearalenone
[6-(10-hydroxy-6-oxo-trans-1-undecenyl)- General.
All chemicals and solvents were reagent grade or
better. Chemicals were purchased from Sigma Chemical Company (St.
Louis, Mo.) unless otherwise noted. All DNA manipulations, if not
described, were carried out by standard procedures (28).
Construction of scFv cloning vector.
scFv, a single-chain
fragment of the antibody variable region antigen-binding protein, is
composed of an immunoglobulin heavy-chain variable domain
(VH) and a light-chain variable domain (V
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Expression of a Functional Antizearalenone
Single-Chain Fv Antibody in Transgenic Arabidopsis
Plants

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-resorcylic
acid lactone] is a mycotoxin produced by members of the genus Fusarium after infection of corn and small grains (14,
24, 25). When fed to animals, the compound causes
hyperestrogenism with symptoms such as enlargement of the uterus and
nipples, vulvar swelling, vaginal prolapse, and infertility (16,
23). In the last 10 years, the expression of specific antibodies
or antibody fragments in plants has attracted great interest (6,
15, 21, 30, 36, 37), and it has shown some potential in improving plant resistance against pathogens (33) and in altering
plant metabolic pathways (1, 27). Recently, we developed a
single-chain Fv (scFv) antibody with high affinity for zearalenone
(38). To explore the possibility of using "plantibodies"
to neutralize mycotoxin through passive immunization of animals in
their feed, as a first step we used the newly cloned antizearalenone
scFv DNA fragment to transform Arabidopsis plants. In this
report, we demonstrate that expression of the antizearalenone scFv gene in transgenic Arabidopsis plants leads to the accumulation
of a soluble scFv plantibody with high affinity for the mycotoxin zearalenone.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
or
V
) joined together by a flexible peptide linker. The
assembly of the antibody sequence from VH, linker, and
V
DNA fragments by PCR is one of the most problematic
steps in scFv cloning (19). The assembly often results in
undetectable amplificates or undefined DNA amplified products of
various sizes. A new phage display vector was constructed to facilitate
cloning and chain shuffling (intermixing of heavy and light chains) and
to increase the efficiency of scFv assembly from VH and
V
cDNA fragments. A 52-bp
SfiI/NotI fragment in pCANTAB5E (Pharmacia
Biotech, Piscataway, N.J.) was replaced with a DNA fragment encoding
the (Gly4Ser)3 linker peptide and with new
restriction sites which rarely exist in V gene regions. To test the
efficacy of the new vector for scFv antibody cloning, an
antizearalenone scFv DNA fragment was cloned and expressed by using
this new vector in Escherichia coli.

View larger version (28K):
[in a new window]
FIG. 1.
Map of phage display vector pEY.5. (A) Restriction map
with unique restriction sites marked. (B) Nucleotide sequence of linker
(boldface) and the VH and V
cloning sites
(underlined) in pEY.5.
Antizearalenone scFv antibody cloning in pEY.5.
VH and V
DNA fragments were reamplified from
previously cloned antizearalenone scFv phagemid DNA (pQY1.5)
(38) using the following restriction site-containing
primers. The primers used for VH DNA reamplification were
VHFORY (5'-TGAGGAGACGGTGACACTAGTGCCTTGGC-3') and
VHBACKY
(5'-ATGACTCGCGGCCCAGCCGGCCATGGCCSAGGTSMARCTGCAGSAGTCWGG-3'), where S = C or G, M = A or C, R = A or G, and W = A
or T. The primers used for V
DNA reamplification were
VKBACKY (5'-TCGGACATCGAGCTCACTCAGTCTCC-3') and
VKFORY
(5'-GAGTCATTCTGCGGCCGCCCGTTTBAKYTCCARCTTKGTSCC-3'), where B = T or C or G, K = T or G, and Y = C or T. The
reamplified VH DNA fragments were digested with
SfiI and SpeI and ligated into pEY.5 digested
with the same enzymes. The ligated products were then digested with
SacI and NotI and ligated with reamplified V
DNA fragments that had been digested with the same
enzymes, yielding pEY.5HL. pEY.5HL phagemid DNA was introduced into
E. coli TG1 for the production of recombinant phages in the
presence of helper phage M13KO7 and into E. coli HB2151 for
soluble scFv antibody production, as described previously
(38). The soluble scFv antibody from E. coli
cultures was characterized with an indirect enzyme-linked immunosorbent
assay (ELISA) (38).
Construction of plant scFv expression plasmids.
The
antizearalenone scFv DNA fragment was amplified from a
zearalenone-binding-positive clone, pEY.5HL3, by PCR using
Pfu DNA polymerase (Stratagene, La Jolla, Calif.) with a
sense primer (5'-TATCCGCGGTATGGCCCAGGTGAAACTGC-3')
containing an SstII site and an antisense primer
(5'-CCCTCTAGACCAGACGTTAGTAAATGAA-3') containing an XbaI site. The amplified DNA fragment was isolated from a
low-melting-point agarose gel, purified with QIAEXII, digested with
XbaI, and ligated into
HincII-XbaI-digested pUC19, yielding pQY2. For
expression without a signal peptide, a
HindIII-XbaI fragment from pQY2 was ligated
directly into the HindIII-XbaI sites of
pKYLX71::35S2 (22), creating pQY4.1-1.
For expression with a plant protein signal sequence, a 110-bp
HindIII-SstII fragment containing the tobacco
pathogenesis-related protein PR-1b signal peptide (SP) sequence from
pSIG3 (a clone with the PR-1b SP sequence [12] ligated
into the EcoRV site of Stratagene's pBluescript SK) was ligated into the HindIII-SstII sites of pQY2,
generating pQY3. Finally, a HindIII-XbaI
fragment containing the SP-scFv fusion fragment from pQY3 was ligated
into the HindIII-XbaI sites of pKYLX71::35S2 (22), creating pQY4.4-1.
Both pQY4.1-1 and pQY4.4-1 were introduced from E. coli
DH5
into Agrobacterium tumefaciens strain GV3850 (39) by triparental mating (11).
Plant transformation. Arabidopsis thaliana ecotype Columbia (GLABROUS1) plants were transformed using a vacuum infiltration protocol similar to the one described by Bechtold et al. (3). Mature seeds from these infiltrated plants were germinated and selected on plant nutrient agar plates (3) supplemented with 50 µg of kanamycin/ml. Kanamycin-resistant seedlings were transferred into soil pots, and the crude protein from leaves of 2-month-old kanamycin-resistant plants was tested for scFv antibody binding activity with ELISA as described below.
Expression of scFv plantibody and ELISA analysis. In order to coat microtiter plate wells with zearalenone for the indirect ELISA, a zearalenone-ovalbumin (ZEN-OVA) conjugate was made as described previously (38). Immulon-4 microtiter wells (Dynatech Laboratories, Inc., Chantilly, Va.) were coated with 1 µg of ZEN-OVA conjugate/well in 100 µl of 0.05 M carbonate-bicarbonate coating buffer (pH 9.4) at 4°C overnight. The wells were washed and blocked as described previously (38). Two or three leaves from 2-month-old transgenic plants were cut and ground with a pestle in a 1.5-ml microcentrifuge tube on ice. After centrifugation at 13,800 × g in a microcentrifuge for 10 min at 4°C, the sap (supernatant) was collected. Fifty microliters of the leaf sap was diluted 1:1 (vol/vol) with 2% nonfat dry milk in phosphate-buffered saline (PBS) and added to each well, followed by incubation at 37°C for 1 h. After washing six times with 320 µl of PBS-0.1% Tween 20 per well, 100 µl of mouse anti-E tag antibody per well (1 µg/ml) was added, followed by addition of goat anti-mouse immunoglobulin G (IgG)-horseradish peroxidase conjugate (diluted 1:2,000 in 2% nonfat dry milk in PBS). Finally, 100 µl of 3,3',5,5'-tetramethylbenzidine (TMB) substrate (Sigma Chemical Company) was added per well and the mixture was incubated at 37°C for 15 min. The reaction was stopped by adding 100 µl of 10% H2SO4 per well. Absorbances at 450 nm were determined with a microtiter plant reader (Molecular Device Corporation, Menlo Park, Calif.).
For the competitive indirect (CI) ELISA, 50 µl of free zearalenone/well at various concentrations (0, 1, 10, 100, and 1,000 ng/ml in PBS containing 1% methanol) was added to ZEN-OVA-coated wells as described previously (38), and then 50 µl of diluted (1:49) sap from the transgenic Arabidopsis plants was added per well. After 1 h of incubation, the bound plantibodies were detected as described above. For comparison, a CI-ELISA was performed simultaneously with bacterial antizearalenone scFv expressed as a soluble protein in E. coli and diluted (1:9). Methanol effects on binding activity were measured for the monoclonal antibody (MAb), bacterial scFv antibody, and scFv plantibody (diluted 10-fold in 10% nonfat milk-PBS) using the CI-ELISA as described above (38). The effect of pH on these antibodies was also tested. The antibodies were diluted (1:5 [vol/vol]) in buffer solutions of pH 2.3 and pH 6.3 (adjusted with 0.05 M citric acid and 0.05 M Na2HPO4) and incubated at 4°C overnight. A portion of the pH 2.3-treated sample was adjusted back to pH 6.3 and incubated at room temperature for 1 h. To wells coated with a zearalenone-keyhole limpet hemocyanin conjugate (1 µg/well), 100 µl of pH-treated antibody sample was added per well. Bound antibodies were measured as described above.Protein analysis. Proteins in leaf sap from independent transgenic plants were separated in a sodium dodecyl sulfate (SDS)-12% polyacrylamide gel. Two identical gels were run at the same time. After electrophoresis, one gel was stained with Coomassie brilliant blue G-250. The proteins in the other gel were transferred to a nitrocellulose membrane (Schleicher & Schuell, Keene, N.H.). Mouse anti-E tag antibody, goat anti-mouse IgG-alkaline phosphatase conjugate (Sigma Chemical Company), and nitroblue tetrazolium-5-bromo-4-chloro-3-indolylphosphate substrate (Pierce, Rockford, Ill.) were used to detect plantibodies in a procedure similar to that previously described (38).
scFv plantibody cytolocation with immunogold labeling. Segments (approximately 0.5 by 1.0 mm) of leaves from 2-month-old transgenic Arabidopsis plants were fixed by vacuum infiltration with 2% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) for 2 h at room temperature. After three washes in the above buffer, the samples were postfixed with 1% osmium tetroxide in 0.1 M sodium cacodylate buffer at room temperature for 2 h followed by dehydration with a graded acetone series. The samples were then embedded by infiltration with Spurtol resin (31; H. Kushida, Letter, J. Electron Microsc. 23:197, 1974). Ultrathin sections were cut and supported on Formvar-coated grids.
The grids containing ultrathin sections were pretreated by incubation in a saturated aqueous solution of sodium metaperiodate as described by Bendayan and Zollinger (4). After a thorough washing in distilled water, the pretreated grids were blocked for 1 h at room temperature in 20 mM Tris-buffered saline (TBS, pH 7.5) containing 0.05% Tween 20, 1% (wt/vol) bovine serum albumin, and 0.01% NaN3. The samples on the grids were then incubated with the primary antibody (mouse anti-E tag antibody) diluted in the blocking buffer for 2 h at room temperature. After four 5-min washings with TBS, the grids were incubated with goat anti-mouse IgG-gold conjugate (10-nm gold particles) (1:20 dilution) for 2 h at room temperature. After four 5-min washings with TBS and two 5-min washings in distilled water, the grids were poststained with 1% uranyl acetate for 30 min, rinsed in distilled water, and then stained with Hanaichi's lead solution (13) for 5 min. The grids were then rinsed in 20 mM NaOH and distilled water and examined with a CM10 transmission electron microscope (Philips, Amsterdam, The Netherlands). Immunogold labeling of sections of nontransformed Arabidopsis thaliana ecotype Columbia was performed as a control.| |
RESULTS |
|---|
|
|
|---|
Cloning of antizearalenone scFv in pEY.5.
To determine the
feasibility of using the new cloning vector pEY.5 for scFv antibody
expression, the DNA fragments of VH and V
from pQY1.5 (38) were reamplified and then recloned into pEY.5 as described in the Materials and Methods section. In E. coli HB2151, one new clone (pEY.5HL3) produced soluble scFv
antibody with high affinity for zearalenone (Fig.
2). The concentration of free zearalenone
required for 50% inhibition of antizearalenone scFv binding to ZEN-OVA
in the microtiter wells, 15.5 ng/ml, was similar to the results
previously described for soluble scFv expressed by pQY1.5
(38). Because VH or V
alone was
cloned in pEY.5 in frame with E tag and g3p, this vector is also
suitable for selecting single-domain Fv antibodies and for chain
shuffling. However, neither VH nor V
alone
from pQY1.5 (38) showed any zearalenone binding activity
when they were cloned into pEY.5 separately (data not shown),
indicating that both VH and V
were required
for the scFv binding to zearalenone. It was notable that E. coli HB2151/pEY.5HL3 grew much slower than HB2151/pEY.5, suggesting that functional antizearalenone scFv expression affected the
growth of the E. coli host cells.
|
Expression of antizearalenone scFv plantibody.
The
antizearalenone scFv DNA fragment from pEY.5HL3 was recloned into a
plant transformation vector to generate clones with and without the
PR-1b SP sequence, pQY4.1-1 and pQY4.4-1, respectively (Fig.
3). About 1% of 20,000 seeds from plants
transformed with GV3850/pQY4.4-1 were kanamycin resistant, whereas
plants transformed with GV3850/pQY4.1-1 produced no kanamycin-resistant
seedlings from approximately 20,000 seeds. In the putative
transgenic (kanamycin-resistant) plants transformed with
GV3850/pQY4.4-1, approximately 20% of the tested plants produced
functional antibody for zearalenone as determined by ELISA. Western
analysis showed that GV3850/pQY4.4-1-transformed Arabidopsis
plants produced a 32-kDa scFv plantibody protein (Fig. 4) that was similar in size to the scFv
antibody produced in E. coli (38). The
specificity and sensitivity of the plantibody to zearalenone was
determined by CI-ELISA (Fig. 2). The plantibody had a 50% inhibitory
concentration of 11.2 ng/ml for zearalenone, showing an affinity for
zearalenone similar to that of the scFv antibody produced by bacteria
and the MAb from hybridoma cell cultures (38).
|
|
Effects of methanol and low pH on plantibody.
ELISAs used to
detect zearalenone in grain all require the use of methanol-water
(70:30) to extract zearalenone from the tissue sample (38).
Because the extraction liquid comes into contact with antibody on the
surface of the microtiter plate, the stability of the antibody in the
presence of methanol is important. As shown previously, antizearalenone
scFv antibody from bacteria exhibited greater sensitivity to methanol
destabilization than the parent MAb (38). To test the
effects of posttranslational modifications on the stability of scFv
antibodies, antizearalenone scFv plantibody was compared with scFv
antibody produced in E. coli and the parental MAb for
stability in methanol and in an acidic environment. The scFv plantibody
from pQY4.4-1-transformed Arabidopsis plants was as
sensitive to methanol destabilization as the soluble scFv expressed in
E. coli (Fig. 5), whereas the
parent MAb exhibited tolerance to much higher concentrations of
methanol. In the low-pH environment (pH 2.3), all three antibodies
(MAb, bacterial scFv antibody, and scFv plantibody) lost binding
activity to zearalenone (Table 1). When
the pH was adjusted back to neutral (pH 6.3), the binding activity was
recovered.
|
|
Localization of antizearalenone scFv plantibody.
Transgenic
Arabidopsis plants expressing antizearalenone scFv antibody
were processed and labeled for electron microscopic immunolocalization
as described in Materials and Methods. Gold particle deposition
indicated that scFv antibody was distributed evenly in electron-dense
areas such as the chloroplast, cytoplasm, nucleus, and endoplasmic
reticulum, suggesting that some expressed plantibody remained inside
the plant cells (Fig. 6A and B and Table
2). The immunogold labeling density in
the electron-thin areas, such as the intercellular spaces and vacuoles,
was dramatically lower than that in the electron-dense areas (Fig. 6A
and Table 2). Incubation of the nontransformed plant sections with the antizearalenone scFv antibody and the gold-labeled anti-IgG antibodies also resulted in discernible gold labeling (Fig. 6C). This finding suggested that antizearalenone scFv antibody was binding to
Arabidopsis cell components. In the nontransformed control
plant samples, very little immunogold labeling was due to nonspecific
binding (Fig. 6D and Table 2).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
In this investigation, an scFv plantibody with high affinity for zearalenone was produced from stable transgenic Arabidopsis plants. To our knowledge, this is the first report of an antimycotoxin antibody gene expressed in plants. Like other scFv plantibodies (5), this antizearalenone scFv plantibody had antigen-binding properties similar to those of bacterially produced scFv antibody.
The antizearalenone scFv DNA fragment was cloned in a newly constructed
vector, pEY.5. This new vector maintained the advantageous features of the original vector, pCANTAB5E
an inducible
lac promoter, a short peptide linker
(Gly4Ser)3, an E tag marker, and an amber stop
codon that allows switching between expression of a membrane-anchored scFv-g3p fusion and expression of a soluble scFv
simply by changing the expression host from E. coli strain TG1 to strain
HB2151. The new vector also allowed the direct cloning of
VH and V
with the introduction of two
rare-cutting restriction enzyme sites (SpeI and
SacI). In the Kabat Database of Sequences of Proteins of
Immunological Interest (http://immuno.bme.nwu.edu), the SpeI recognition sequence was found in less than 1% of 4,701 known murine
VH chains and 1% of 2,492 known murine V
chains. SacI has a slightly higher cutting frequency but
accounts for only 4.5 and 2.3% of known VH and
V
chains, respectively. Therefore, the majority of
variable region cDNAs would be free from internal cutting. We tested
the feasibility of this new vector by cloning and expressing an
antizearalenone scFv in E. coli. By utilizing the
SfiI/SpeI or SacI/NotI
sites, this new vector could also facilitate chain shuffling, which may
be useful for cloning compatible variable chains and improving
antigen-binding ability (18).
For plant transformation, two constructs of the antizearalenone scFv were made by fusion with or without the N-terminal SP from the tobacco pathogenesis-related protein PR-1b, which has been used to secrete foreign proteins into the plant apoplast (9, 20). The PR-1b signal sequence was included with the expectation that it would target the fusion protein to the endoplasmic reticulum, where the SP would be cleaved and the scFv protein would be transported to the apoplast via the default pathway (7). Plants transformed with this signal-sequence-containing construct produced many transformants expressing scFv plantibody with high affinity for zearalenone. However, electron microscopic immunolocalization indicated the presence of the scFv plantibody mainly in the cytoplasm (Fig. 6 and Table 2). Only a low level of labeling signals was found in the intercellular space and was limited to those parts of the intercellular space that were filled with electron-dense material. The labeling signals in the cytoplasm might have reflected binding activity of antizearalenone scFv to some plant cell components, since immunogold labeling showed that antizearalenone scFv antibody binds to nontransformed Arabidopsis cell components in the cytoplasm (Fig. 6C). Although some antibodies or antibody fragments that have been fused with plant signal sequences have been confirmed by immunogold electron microscopy as being secreted through the cell wall into intercellular spaces, despite limitations in cell wall porosity (8), other antibodies were retained in the endoplasmic reticulum compartment or in the cytoplasm (1, 10, 29). The construct without the signal sequence failed to generate any transgenic plants in this study. One explanation might be that the high accumulation of antizearalenone scFv in the plant cytoplasm and the sequential binding to plant cell components were toxic to the host plant cell.
As previously reported, antizearalenone scFv antibody produced from bacteria had greater sensitivity to methanol destabilization than its parent MAb. One possible explanation may be the differences between prokaryotes and eukaryotes in posttranslational protein modifications, especially glycosylation. N-linked glycosylation of proteins in plants is very similar to the glycosylation process in mammals (17, 32). Possible plant posttranslational changes in addition to glycosylation include fatty acylation, phosphorylation, sulfation, and modifications that change the pI of the protein (17). The comparison between antibodies produced in bacteria and plants may help elucidate the role of posttranslational modifications in stabilizing the antibodies. Unfortunately, it was not possible to test the hypothesis that differences between antizearalenone scFv antibody and its parent MAb in methanol sensitivity reflect structural differences derived from posttranslational modifications, because the antizearalenone scFv lacks the canonical Asn-X-Ser/Thr signal sequence for glycosylation. The small differences observed between plantibody and bacterial scFv (Fig. 5 and Table 1) may be attributable to the use of crude scFv preparations rather than purified scFv. Also, the CI-ELISA was not optimized for the crude scFv preparations.
Some mycotoxins not only cause toxic effects in animals and humans but also serve as virulence factors of the producing fungi for causing plant diseases. The mycotoxin zearalenone has been reported to cause certain phytotoxicities (26, 34, 35). The expression of antizearalenone antibody in plants might be useful in reducing the severity of plant diseases associated with this mycotoxin.
Antibodies have been used successfully as antidotes for some low-molecular-weight toxins, through passive immunization (2). However, large quantities of antibody are generally required for passive immunization in vivo. The prospect of harvesting antibody on an agricultural scale offers the potential for economical production of almost limitless amounts of antibody. The production of antibody in edible plants makes it possible to deliver large amounts of toxin-specific antibody through food. Feed-delivered antibody could theoretically bind zearalenone in the intestine, provided that the antibody can survive passage through the acidic stomach environment. When the antizearalenone antibody was subjected to low pH, the MAb and scFv antibodies from both bacteria and plants lost their binding ability. However, all three antibodies recovered binding activity when the pH was adjusted back to neutral (pH 6.3). This suggests that the pH effects on binding activity are not the result of irreversible denaturation. Thus, provided that these antibodies survive proteolysis in the gut, they could bind to zearalenone in the small intestine, where the pH is close to neutral. Whether the antizearalenone plantibody reported in this study will neutralize zearalenone in animal feed and thus reduce toxicity will be determined in the future.
The expression of mycotoxin-specific plantibody could have a role in the development of new or novel forms of plant resistance for some mycotoxins that are important for the initiation or development of plant diseases, especially if catalytic plantibodies that degrade mycotoxins could be developed and expressed in crops.
The most promising role for plantibodies is their potential for large-scale production in plants. Plants are relatively easy and inexpensive to produce, and the equipment already exists for harvesting and processing large volumes of plant material. The prospect of harvesting antibody or antibody fragments on an agricultural scale would mean that antibodies would be available extremely cheaply in almost limitless amounts. In addition, plants are capable of targeting proteins to a number of different tissues for long-term storage and distribution. Although there may be safety concerns about using plantibodies in therapy, antibodies produced in plants also could be used for in vitro diagnosis and for environmental detoxification.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by USDA-NRI grant no. 9702545, Michigan State University Agricultural Experiment Station, the MSU Crop and Food Bioprocessing Center, and the MSU National Food Safety and Toxicology Center.
We thank Jing Yuan for her help in plant transformation.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Botany and Plant Pathology, Michigan State University, East Lansing, MI 48824. Phone: (517) 353-9428. Fax: (517) 353-5598. E-mail: hartL{at}msu.edu.
Present address: The Institute for Genomic Research, Rockville, MD 20850.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Artsaenko, O., M. Peisker, U. zur Nieden, U. Fiedler, E. W. Weiler, K. Muntz, and U. Conrad. 1995. Expression of a single-chain Fv antibody against abscisic acid creates a wilty phenotype in transgenic tobacco. Plant J. 8:745-750[CrossRef][Medline]. |
| 2. | Baud, F. J., S. W. Borron, J. M. Scherrmann, and C. Bismuth. 1997. A critical review of antidotal immunotherapy for low molecular weight toxins. Current antidotes and perspectives. Arch. Toxicol. Suppl. 19:271-287[Medline]. |
| 3. | Bechtold, N., J. Ellis, and G. Pelletier. 1993. In planta Agrobacterium mediated gene transfer by infiltration of adult Arabidopsis thaliana plants. C. R. Acad. Sci. Ser. III 316:1194-1199. |
| 4. | Bendayan, M., and M. Zollinger. 1983. Ultrastructural localization of antigenic sites on osmium-fixed tissues applying the protein A-gold technique. J. Histochem. Cytochem. 31:101-109[Abstract]. |
| 5. | Bruyns, A. M., G. De Jaeger, M. De Neve, C. De Wilde, M. Van Montagu, and A. Depicker. 1996. Bacterial and plant-produced scFv proteins have similar antigen-binding properties. FEBS Lett. 386:5-10[CrossRef][Medline]. |
| 6. | Conrad, U., and U. Fiedler. 1994. Expression of engineered antibodies in plant cells. Plant Mol. Biol. 26:1023-1030[CrossRef][Medline]. |
| 7. |
Denecke, J.,
J. Bottermann, and R. Deblaere.
1990.
Protein secretion in plant cells can occur via the default pathway.
Plant Cell
2:51-59 |
| 8. | De Wilde, C., M. De Neve, R. De Rycke, A. M. Bruyns, G. De Jaeger, M. Van Montagu, A. Depicker, and G. Engler. 1996. Intact antigen-binding MAK33 antibody and F-ab fragment accumulate in intercellular spaces of Arabidopsis thaliana. Plant Sci. 114:233-241. |
| 9. | Dixon, D. C., J. R. Cutt, and D. F. Klessig. 1991. Differential targeting of the tobacco PR-1 pathogenesis-related proteins to the extracellular space and vacuoles of crystal idioblasts. EMBO J. 10:1317-1324[Medline]. |
| 10. | Düring, K., S. Hippe, F. Kreuzaler, and J. Schell. 1990. Synthesis and self-assembly of a functional monoclonal antibody in transgenic Nicotiana tabacum. Plant Mol. Biol. 15:281-293[CrossRef][Medline]. |
| 11. |
Figurski, D., and D. R. Helinski.
1979.
Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans.
Proc. Natl. Acad. Sci. USA
76:1648-1652 |
| 12. | Gopalan, S., D. W. Bauer, J. R. Alfano, A. O. Loniello, S. Y. He, and A. Collmer. 1996. Expression of the Pseudomonas syringae avirulence protein AvrB in plant cells alleviates its dependence on the hypersensitive response and pathogenicity (Hrp) secretion system in eliciting genotype-specific hypersensitive cell death. Plant Cell 8:1095-1105[Abstract]. |
| 13. |
Hanaichi, T.,
T. Sato,
T. Iwamoto,
J. Malavasi-Yamashiro,
M. Hoshino, and N. Mizuno.
1986.
A stable lead by modification of Sato's method.
J. Electron Microsc.
35:304-306 |
| 14. | Hart, L. P., W. E. Braselton, and T. C. Stebbins. 1982. Production of zearalenone and deoxynivalenol in commercial sweet corn. Plant Dis. 66:1133-1135. |
| 15. | Hiatt, A., and J. K. Ma. 1992. Monoclonal antibody engineering in plants. FEBS Lett. 307:71-75[CrossRef][Medline]. |
| 16. | Hidy, P. H., R. S. Baldwin, R. L. Greasham, C. L. Keith, and J. R. McMullen. 1977. Zearalenone and some derivatives: production and biological activities. Adv. Appl. Microbiol. 22:59-82[Medline]. |
| 17. | Jones, R. L., and D. G. Robinson. 1989. Protein secretion in plants. Tansley Rev. 17:567-588. |
| 18. |
Kang, A. S.,
T. M. Jones, and D. R. Burton.
1991.
Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries.
Proc. Natl. Acad. Sci. USA
88:11120-11123 |
| 19. | Kramer, K., and B. Hock. 1996. Recombinant single-chain antibodies against s-triazines. Food Agric. Immunol. 8:97-109. |
| 20. | Lund, P., and P. Dunsmuir. 1992. A plant signal sequence enhances the secretion of bacterial ChiA in transgenic tobacco. Plant Mol. Biol. 18:47-53[CrossRef][Medline]. |
| 21. | Ma, J. K. C., and M. B. Hein. 1995. Plant antibodies for immunotherapy. Plant Physiol. 109:341-346[CrossRef][Medline]. |
| 22. |
Maiti, I. B.,
J. F. Murphy,
J. G. Shaw, and A. G. Hunt.
1993.
Plants that express a potyvirus proteinase gene are resistant to virus infection.
Proc. Natl. Acad. Sci. USA
90:6110-6114 |
| 23. | Mirocha, C. J., and C. M. Christensen. 1974. Oestrogenic mycotoxins synthesized by Fusarium, p. 129-148. In I. F. H. Purchase (ed.), Mycotoxins. Elsevier Scientific Publishing Co., Amsterdam, The Netherlands. |
| 24. | Mirocha, C. J., C. M. Christensen, and G. H. Nelson. 1971. F-2 (zearalenone) estrogenic mycotoxin from Fusarium, p. 107-138. In S. Kadis, A. Ciegler, and S. J. Ayl (ed.), Microbial toxins, vol. 7. Academic Press, New York, N.Y. |
| 25. | Mirocha, C. J., S. V. Pathre, and C. M. Christensen. 1977. Zearalenone, p. 345-364. In J. V. Rodricks, C. W. Hesseltine, and M. A. Mehlman (ed.), Mycotoxins in human and animal health. Pathotox Publishers, Inc., Forest Park, Ill. |
| 26. | Nedelnik, J. 1993. Phytotoxicity of some Fusarium spp. toxins to clover plants. Ochr. Rostl. 29:69-76. |
| 27. | Owen, M., A. Gandecha, B. Cockburn, and G. Whitelam. 1992. Synthesis of a functional anti-phytochrome single-chain Fv protein in transgenic tobacco. Bio/Technology 10:790-794[CrossRef][Medline]. |
| 28. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 29. | Schouten, A., J. Roosien, J. M. de Boer, A. Wilmink, M. N. Rosso, D. Bosch, W. J. Stiekema, F. J. Gommers, J. Bakker, and A. Schots. 1997. Improving scFv antibody expression levels in the plant cytosol. FEBS Lett. 415:235-241[CrossRef][Medline]. |
| 30. | Smith, M. D. 1996. Antibody production in plants. Biotechnol. Adv. 14:267-281. |
| 31. | Spurr, A. R. 1969. A low-viscosity epoxy resin embedding medium for electron microscopy. J. Ultrastruct. Res. 26:31-43[CrossRef][Medline]. |
| 32. |
Sturm, A.,
A. V. Kuik,
J. F. G. Vliegenthart, and M. J. Crispeels.
1987.
Structure, position, and biosynthesis of the high mannose and the complex oligosaccharide side chains of the bean storage protein phaseolin.
J. Biol. Chem.
262:13392-13403 |
| 33. | Tavladoraki, P., E. Benvenuto, S. Trinca, M. D. De, A. Cattaneo, and P. Galeffi. 1993. Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack. Nature 366:469-472[CrossRef][Medline]. |
| 34. | Vianello, A., and F. Macri. 1981. Effect of zearalenone (F-2) on pea (Pisum sativum cultivar Alaska) stem, maize (Zea mays cultivar DeKalb XL 342) root and rat liver mitochondria. Planta 153:443-446[CrossRef]. |
| 35. | Wakulinski, W. 1989. Phytotoxicity of the secondary metabolites of fungi causing wheat head fusariosis (head blight). Acta Physiol. Plant. 11:301-306. |
| 36. | Whitelam, G. C. 1995. The production of recombinant proteins in plants. J. Sci. Food Agric. 68:1-9. |
| 37. | Whitelam, G. C., and W. Cockburn. 1996. Antibody expression in transgenic plants. Trends Plant Sci. 1:268-272[CrossRef]. |
| 38. | Yuan, Q., J. R. Clarke, H.-R. Zhou, J. E. Linz, J. J. Pestka, and L. P. Hart. 1997. Molecular cloning, expression, and characterization of a functional single-chain Fv antibody to the mycotoxin zearalenone. Appl. Environ. Microbiol. 63:263-269[Abstract]. |
| 39. | Zambryski, P., H. Joos, C. Gentello, J. Leemans, M. Van Montagu, and J. Schell. 1983. Ti-plasmid vector for the introduction of DNA into plant cells without altering their normal regeneration capacity. EMBO J. 2:2143-2150[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»